Plasma trace elements and cognitive function in older men and women: The Rancho Bernardo study

Journal of Nutrition, Health and Aging

Volumn 12, Issue 1, 2008, Pages 22-27

  Lam, P K ^a   Kritz Silverstein, Donna ^a   Barrett Connor, Elizabeth ^a   Milne, D ^b   Nielsen, F ^b   Gamst, A ^a   Morton, D ^a   Wingard, D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Cognitive function; Copper; Iron; Trace elements; Zinc

Indexed keywords

COPPER; IRON; TRACE ELEMENT; ZINC;

AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; COGNITION; COGNITIVE DEFECT; COMMUNITY CARE; CONTROLLED STUDY; COPPER BLOOD LEVEL; EDUCATION; ESTROGEN THERAPY; EXERCISE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RECALL; REGRESSION ANALYSIS; SEX DIFFERENCE; SMOKING; ZINC BLOOD LEVEL;

EID: 38549157083     PISSN: 12797707     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02982160     Document Type: Article

References (42)

1. Mack JL, Whitehouse PJ. Quality of Life in Dementia: state of the art - report of the International Working Group for Harmonization of Dementia Drug Guidelines and the Alzheimer's Society satellite meeting. Alzheimer Dis Assoc Disord 2001;15:69-71.
2. Hemels ME, Lanctot KL, Iskedjian M, Einarson TR. Clinical and economic factors in the treatment of behavioural and psychological symptoms of dementia. Drugs Aging 2001;18:527-50.
3. Dewey ME, Saz P. Dementia, cognitive impairment and mortality in persons aged 65 and over living in the community: a systematic review of the literature. Int J Geriatr Psychiatry 2001;16:751-61.
4. Fichter MM, Meller I, Schroppel H, Steinkirchner R. Dementia and cognitive impairment in the oldest old in the community. Prevalence and comorbidity. Br J Psychiatry 1995;166:621-9.
5. Graham JE, Rockwood K, Beattie BL, et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997;349:1793-6.
6. Hanninen T, Koivisto K, Reinikainen KJ, et al. Prevalence of ageing-associated cognitive decline in an elderly population. Age Ageing 1996;25:201-5.
7. Schroder J, Kratz B, Pantel J, Minnemann E, Lehr U, Sauer H. Prevalence of mild cognitive impairment in an elderly community sample. J Neural Transm Suppl 1998;54:51-9.
8. Unverzagt FW, Gao S, Baiyewu O, et al. Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging. Neurology 2001;57:1655-62.
9. Gonzalez-Gross M, Marcos A, Pietrzik K. Nutrition and cognitive impairment in the elderly. Br J Nutr 2001;86:313-21.
10. Vellas B, Lauque S, Andrieu S, et al. Nutrition assessment in the elderly. Curr Opin Clin Nutr Metab Care 2001;4:5-8.
11. Ekmekcioglu C. The role of trace elements for the health of elderly individuals. Nahrung 2001;45:309-16.
12. Sandstead HH. Nutrition and brain function: trace elements. Nutr Rev 1986;44 Suppl:37-41.
13. Sandstead HH. Causes of iron and zinc deficiencies and their effects on brain. J Nutr 2000;130:347S-9S.
14. Sandstead HH, Frederickson CJ, Penland JG. History of zinc as related to brain function. J Nutr 2000;130:496S-502S.
15. Gonzalez C, Martin T, Cacho J, et al. Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers. Eur J Clin Invest 1999;29:637-42.
16. Ozcankaya R, Delibas N, Malondialdehyde, superoxide dismutase, melatonin, iron, copper, and zinc blood concentrations in patients with Alzheimer disease: cross-sectional study. Croat Med J 2002;43:28-32.
17. Squitti R, Lupoi D, Pasqualetti P, et al. Elevation of serum copper levels in Alzheimer's disease. Neurology 2002;59:1153-61.
18. Chandra RK. Effect of vitamin and trace-element supplementation on cognitive function in elderly subjects. Nutrition 2001;17:709-12.
19. Baker H, De Angelis B, Baker EF, Frank O, Jaslowdagger SP. Lack of effect of 1 year intake of a high-dose vitamin and mineral supplement on cognitive function of elderly women. Gerontology 1999;45:195-9.
20. Gray SL, Hanlon JT, Landerman LR, Artz M, Schmader KE, Gillenbaum GG. Is antioxidant use protective of cognitive function in the community-dwelling elderly? Am J Geriatr Pharmacother 2003;1:3-10.
21. Yaffe K, Clemmons TE, McBee WL, Linblad AS: Age-Related Eye Disease Study Research Group. Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial. Neurology. 2004;63:1705-7.
22. Cuajungco MP, Faget KY. Zinc takes the center stage: its paradoxical role in Alzheimer's disease. Brain Res Brain Res Rev 2003;41:44-56.
23. Criqui MH, Barrett-Connor E, Austin M. Differences between respondents and non-respondents in a population-based cardiovascular disease study. Am J Epidemiol 1978;108:367-72.
24. Spreen O, Strauss E. A compendium of neuropsychological tests: administration, norms, and commentary. New York: Oxford University Press, 1998.
25. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968;114:797-811.
26. Buschke H, Fuld PA. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 1974;24:1019-25.
27. Russell EW. A mulitple scoring method for the assessment of complex memory functions. J Consult Clin Psychol 1975;43:800-9.
28. Wechsler D. A standardized memory scale for clinical use. J Psychol 1945;19:87-95.
29. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
30. Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 1992;40:922-35.
31. Reitan R. Validity of the Trail-Making Test as an indicator of organic brain disease. Percept Mot Skills 1958;8:271-6.
32. Borkowski JB, Benton AL, Spreen O. Word fluency and brain damage. Neuropsychologia 1967;5:135-40.
33. Barrett-Connor E, Kritz-Silverstein D. Gender differences in cognitive function with age: the Rancho Bernardo study. J Am Geriatr Soc 1999;47:159-64.
34. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43-6.
35. Hinks LJ, Clayton BE, Lloyd RS. Zinc and copper concentrations in leucocytes and erythrocytes in healthy adults and the effect of oral contraceptives. J Clin Pathol 1983;36:1016-21.
36. Rubinfeld Y, Maor Y, Simon D, Modai D. A progressive rise in serum copper levels in women taking oral contraceptives: a potential hazard? Fertil Steril 1979;32:599-601.
37. Barrett-Connor E, Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA 1993;269:2637-41.
38. Thompson KJ, Shoham S, Connor JR. Iron and neurodegenerative disorders. Brain Res Bull 2001;55:155-64.
39. Youdim MB, Ben Shachar D, Riederer P. Iron in brain function and dysfunction with emphasis on Parkinson's disease. Eur Neurol 1991;31 Suppl 1:3440.:34-40.
40. Tumlund JR. Copper. In: Shils M et al., eds. Modern Nutrition in Health and Disease. Baltimore: Williams & Wilkins, 1999:241-52.
41. Beard J. Nutritional Status and Central Nervous System Function. In: Ziegler EE, Filer LJ Jr, eds. Present Knowledge in Nutrition. Washington, D.C.: ILSI Press, 1996:612-4.
42. Horning MS, Blakemore LJ, Trombley PQ. Endogenous mechanisms of neuroprotection: role of zinc, copper, and camosine. Brain Res 2000;852:56-61.